Your browser doesn't support javascript.
loading
Bevacizumab in advanced endometrial cancer.
Rubinstein, Maria M; Dickinson, Shannan; Narayan, Priyanka; Zhou, Qin; Iasonos, Alexia; Ma, Weining; Lakhman, Yulia; Makker, Vicky.
Afiliação
  • Rubinstein MM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: rubinstm@mskcc.org.
  • Dickinson S; Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Narayan P; Weil Cornell Medical College, New York, NY, USA.
  • Zhou Q; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iasonos A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ma W; Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lakhman Y; Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Makker V; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gynecol Oncol ; 161(3): 720-726, 2021 06.
Article em En | MEDLINE | ID: mdl-33894982

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Bevacizumab / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Bevacizumab / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article